T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Constellation Brands
STZ
$22.9B
| $91.1M | 0.01% |
462,548
-73,375
| -14% | -$14.3M |
|
|
AMRN
677
Amarin Corp
AMRN
$297M
| $90.7M | 0.01% |
233,992
-8,613
| -4% | -$3.15M |
|
|
ALDR
678
DELISTED
Alder Biopharmaceuticals
ALDR
| $90.6M | 0.01% |
7,694,119
-1,411,448
| -16% | -$17.1M |
|
679
Myers Industries
MYE
$1.23B
| $89.5M | 0.01% |
4,643,215
-41,763
| -0.9% | -$752K |
|
|
RST
680
DELISTED
ROSETTA STONE INC
RST
| $88.8M | 0.01% |
3,879,288
+1,159,027
| +43% | +$27.9M |
|
|
DISH
681
DELISTED
DISH Network Corp.
DISH
| $88.7M | 0.01% |
2,308,313
-1,179,519
| -34% | -$41.9M |
|
682
Churchill Downs
CHDN
$6.17B
| $88.6M | 0.01% |
1,540,360
+7,268
| +0.5% | +$365K |
|
683
TSMC
TSM
$2.23T
| $88.5M | 0.01% |
2,260,535
+979,464
| +76% | +$40.3M |
|
684
Teva Pharmaceuticals
TEVA
$42.8B
| $88.2M | 0.01% |
9,553,328
+1,593,139
| +20% | +$19.2M |
|
685
Live Oak Bancshares
LOB
$1.98B
| $87.9M | 0.01% |
5,127,488
-2,402
| -0% | -$39.5K |
|
686
Coca-Cola Consolidated
COKE
$12.6B
| $87.6M | 0.01% |
2,928,050
-853,010
| -23% | -$26.7M |
|
687
AZZ Inc
AZZ
$4.55B
| $86.8M | 0.01% |
1,885,224
-666
| -0% | -$29.8K |
|
688
Exelon
EXC
$46.6B
| $86.7M | 0.01% |
2,535,029
+39,658
| +2% | +$1.4M |
|
689
Zebra Technologies
ZBRA
$17.9B
| $86.5M | 0.01% |
413,130
-5,989
| -1% | -$1.21M |
|
|
TPH
690
DELISTED
Tri Pointe Homes
TPH
| $86.5M | 0.01% |
7,225,327
-1,110,801
| -13% | -$14.5M |
|
691
Harmonic Inc
HLIT
$1.3B
| $86.5M | 0.01% |
15,578,241
-318,277
| -2% | -$1.77M |
|
692
MaxLinear
MXL
$6.74B
| $86.4M | 0.01% |
3,688,078
+34,198
| +0.9% | +$833K |
|
|
THR
693
DELISTED
Thermon Group Holdings
THR
| $86.1M | 0.01% |
3,355,490
-285,890
| -8% | -$7.13M |
|
|
MASI
694
DELISTED
Masimo
MASI
| $85.7M | 0.01% |
575,571
+12,395
| +2% | +$1.7M |
|
|
RDFN
695
DELISTED
Redfin
RDFN
| $85.6M | 0.01% |
4,761,638
-7,619,968
| -62% | -$146M |
|
|
IMMU
696
DELISTED
Immunomedics Inc
IMMU
| $85.3M | 0.01% |
6,150,864
-2,959,466
| -32% | -$44.5M |
|
|
HMSY
697
DELISTED
HMS Holdings Corp.
HMSY
| $85.2M | 0.01% |
2,629,880
+14,227
| +0.5% | +$435K |
|
|
JAG
698
DELISTED
Jagged Peak Energy Inc.
JAG
| $85M | 0.01% |
10,274,274
-5,652,637
| -35% | -$54.8M |
|
699
Expro Ltd
XPRO
$2.07B
| $84.7M | 0.01% |
2,584,810
+363,387
| +16% | +$13.1M |
|
|
AEGN
700
DELISTED
Aegion Corp
AEGN
| $84.6M | 0.01% |
4,598,683
+688,340
| +18% | +$11.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.